Gainers
- Kiniksa Pharmaceuticals (NASDAQ:KNSA) shares rose 23.1% to $89.86 during Tuesday's regular session. The market value of their outstanding shares is at $5.6 billion. As per the press release, Q3 earnings came out today.
- PDS Biotechnology (NASDAQ:PDSB) shares moved upwards by 18.77% to $1.26. The market value of their outstanding shares is at $77.1 million.
- Aardvark Therapeutics (NASDAQ:AARD) shares rose 17.59% to $1.27. The company's market cap stands at $23.6 million.
- Moleculin Biotech (NASDAQ:MBRX) stock increased by 17.43% to $8.32. The market value of their outstanding shares is at $7.2 million.
- Pomdoctor (NASDAQ:POM) shares rose 16.81% to $1.32. The company's market cap stands at $3.1 million.
- Zura Bio (NASDAQ:ZURA) shares rose 16.57% to $4.15. The market value of their outstanding shares is at $341.1 million. As per the news, the Q3 earnings report came out today.
Losers
- Baird Medical Investment (NASDAQ:BDMD) shares fell 41.3% to $0.25 during Tuesday's regular session. The company's market cap stands at $13.7 million.
- SciSparc (NASDAQ:SPRC) shares fell 35.35% to $0.83.
- Artiva Biotherapeutics (NASDAQ:ARTV) shares fell 31.25% to $4.24. The market value of their outstanding shares is at $301.1 million.
- Actuate Therapeutics (NASDAQ:ACTU) shares declined by 25.21% to $0.39. The market value of their outstanding shares is at $12.6 million.
- Universe Pharmaceuticals (NASDAQ:UPC) shares fell 23.31% to $2.21. The market value of their outstanding shares is at $14.4 million.
- Imunon (NASDAQ:IMNN) shares declined by 22.12% to $0.96. The company's market cap stands at $6.9 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Market News and Data brought to you by Benzinga APIs
© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.


